175 related articles for article (PubMed ID: 14677066)
1. A novel cell line and xenograft model of ampulla of Vater adenocarcinoma.
Sorio C; Moore PS; Ennas MG; Tecchio C; Bonora A; Sartoris S; Balzarini P; Grigolato P; Scarpa A
Virchows Arch; 2004 Mar; 444(3):269-77. PubMed ID: 14677066
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
3. Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Takahashi N; Aoyama F; Hiyoshi M; Kataoka H; Sawaguchi A
Int J Oncol; 2014 Apr; 44(4):1139-45. PubMed ID: 24481592
[TBL] [Abstract][Full Text] [Related]
4. Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
Mohammad RM; Li Y; Mohamed AN; Pettit GR; Adsay V; Vaitkevicius VK; Al-Katib AM; Sarkar FH
Pancreas; 1999 Nov; 19(4):353-61. PubMed ID: 10547195
[TBL] [Abstract][Full Text] [Related]
5. Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater.
Schiergens TS; Reu S; Neumann J; Renz BW; Niess H; Boeck S; Heinemann V; Bruns CJ; Jauch KW; Kleespies A
Surgery; 2015 Jul; 158(1):151-61. PubMed ID: 25819575
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK
Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
8. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of pancreatic and periampullary collision cancers.
Niu GM; Jin DY; Ji Y; Hou J; Wang DS; Lou WH
J Dig Dis; 2010 Aug; 11(4):231-6. PubMed ID: 20649736
[TBL] [Abstract][Full Text] [Related]
10. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
[TBL] [Abstract][Full Text] [Related]
11. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
Hustinx SR; Hruban RH; Leoni LM; Iacobuzio-Donahue C; Cameron JL; Yeo CJ; Brown PN; Argani P; Ashfaq R; Fukushima N; Goggins M; Kern SE; Maitra A
Cancer Biol Ther; 2005 Jan; 4(1):83-6. PubMed ID: 15662124
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater.
Sohn BS; Yuh YJ; Kim KH; Jeon TJ; Kim NS; Kim SR
Tumori; 2013; 99(2):139-44. PubMed ID: 23748804
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
14. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS
Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108
[TBL] [Abstract][Full Text] [Related]
15. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenesis of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms.
Esposito I; Friess H; Büchler MW
Langenbecks Arch Surg; 2001 Apr; 386(3):163-71. PubMed ID: 11382316
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
Senatore FJ; Ynson ML; Dasanu CA
J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.
Jiang ZQ; Varadhachary G; Wang X; Kopetz S; Lee JE; Wang H; Shroff R; Katz M; Wolff RA; Fleming J; Overman MJ
Ann Oncol; 2013 Sep; 24(9):2349-53. PubMed ID: 23704197
[TBL] [Abstract][Full Text] [Related]
19. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic diseases of the papilla of Vater.
Kimura W; Futakawa N; Zhao B
J Hepatobiliary Pancreat Surg; 2004; 11(4):223-31. PubMed ID: 15368105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]